Hypothermic kidney preservation: A remembrance of the past in the future?

Current Opinion in Organ Transplantation

Volumn 16, Issue 2, 2011, Pages 162-168

  Timsit, Marc Olivier ^a,b   Tullius, Stefan G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

cold storage; kidney transplantation; machine perfusion; organ preservation; shearstress

Indexed keywords

2 OXOGLUTARIC ACID; CELSIOR; HISTIDINE; MACROGOL; PRESERVATION SOLUTION; TRYPTOPHAN; UNIVERSITY OF WISCONSIN SOLUTION;

ARTICLE; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HUMAN; KIDNEY; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MACHINE; NONHUMAN; ORGAN PRESERVATION; OXYGENATION;

COLD ISCHEMIA; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; NEPHRECTOMY; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PULSATILE FLOW; TISSUE DONORS; TREATMENT OUTCOME;

EID: 79954591397     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283446b07     Document Type: Article

References (78)

1. Pirenne J. Time to think out of the (ice) box. Curr Opin Organ Transplant 2010; 15:147-149.
2. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988; 45:673-676.
3. Carrel A, Lindbergh CA. The culture of whole organs. Science 1935; 81:621-623.
4. Belzer FO, Ashby BS, Gulyassy PF, Powell M. Successful seventeen-hour preservation and transplantation of human-cadaver kidney. N Engl J Med 1968; 278:608-610.
5. Lee CY, Mangino MJ. Preservation methods for kidney and liver. Organogenesis 2009; 5:105-112.
6. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980; 28:295-302. (Pubitemid 10025665)
7. Lindell SL, Gandolph D, Southard JH, Belzer FO. Comparison of PBS, HTK, and UW solutions for kidney preservation. Transplant Proc 1991; 23:2399-2401.
8. De Boer J, De Meester J, Smits JM, et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro- Collins. Transpl Int 1999; 12:447-453. (Pubitemid 30009069)
9. Roels L, Coosemans W, Donck J, et al. Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. Transplantation 1998; 66:1660-1664. (Pubitemid 29034987)
10. Opelz G, Dohler B. Multicenter analysis of kidney preservation. Transplantation 2007; 83:247-253.
11. Agarwal A, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Transplantation 2006; 81:480-482. (Pubitemid 43255739)
12. Lynch RJ, Kubus J, Chenault RH, et al. Comparison of histidine- tryptophanketoglutarate and University of Wisconsin preservation in renal transplantation. Am J Transplant 2008; 8:567-573. (Pubitemid 351287525)
13. Stewart ZA, Cameron AM, Singer AL, et al. Histidine-tryptophan- ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 2009; 9:286-293.
14. Stewart ZA, Cameron AM, Singer AL, et al. Histidine-tryptophan- ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 2009; 9:217-221.
15. Muhlbacher F, Langer F, Mittermayer C. Preservation solutions for transplantation. Transplant Proc 1999; 31:2069-2070. (Pubitemid 29376529)
16. Yuan X, Theruvath AJ, Ge X, et al. Machine perfusion or cold storage in organ transplantation: indication, mechanisms, and future perspectives. Transpl Int 2010; 23:561-570.
17. Englesbe MJ, Heidt D, Sung R, Pietroski R. Does using HTK solution for cold perfusion of cadaveric kidneys save money? Transplantation 2006; 82:580-581. (Pubitemid 44290270)
18. Fridell JA, Mangus RS, Powelson JA. Histidine-tryptophan-ketoglutarate for pancreas allograft preservation: the Indiana University experience. Am J Transplant 2010; 10:1284-1289.
19. Menasche P, Termignon JL, Pradier F, et al. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg 1994; 8:207-213.
20. Roberts RF, Nishanian GP, Carey JN, et al. A comparison of the new preservation solution Celsior to Euro-Collins and University of Wisconsin solutions in lung reperfusion injury. Transplantation 1999; 67:152-155. (Pubitemid 29061153)
21. Faenza A, Catena F, Nardo B, et al. Kidney preservation with University of Wisconsin and Celsior solution: a prospective multicenter randomized study. Transplantation 2001; 72:1274-1277. (Pubitemid 33026608)
22. Baertschiger RM, Berney T, Morel P. Organ preservation in pancreas and islet transplantation. Curr Opin Organ Transplant 2008; 13:59-66.
23. Lopez-Andujar R, Deusa S, Montalva E, et al. Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior. Liver Transpl 2009; 15:1709-1717.
24. Hauet T, Eugene M. A new approach in organ preservation: potential role of new polymers. Kidney Int 2008; 74:998-1003.
25. Dutheil D, Rioja-Pastor I, Tallineau C, et al. Protective effect of PEG 35,000 Da on renal cells: paradoxical activation of JNK signaling pathway during cold storage. Am J Transplant 2006; 6:1529-1540. (Pubitemid 43945793)
26. Wang W, Xiong W, Wan J, et al. The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress. Nanotechnology 2009; 20:105103.
27. Dutheil D, Underhaug Gjerde A, Petit-Paris I, et al. Polyethylene glycols interact with membrane glycerophospholipids: is this part of their mechanism for hypothermic graft protection? J Chem Biol 2009; 2:39-49.
28. Liu G, Fu L, Zhang G. Role of hydrophobic interactions in the adsorption of poly(ethylene glycol) chains on phospholipid membranes investigated with a quartz crystal microbalance. J Phys Chem B 2009; 113:3365-3369.
29. Collins GM, Wicomb WN, Levin BS, et al. Heart preservation solution containing polyethyleneglycol: an immunosuppressive effect? Lancet 1991; 338:890-891.
30. Itasaka H, Burns W, Wicomb WN, et al. Modification of rejection by polyethylene glycol in small bowel transplantation. Transplantation 1994; 57:645-648. (Pubitemid 24106757)
31. Giraud S, Claire B, Eugene M, et al. A new preservation solution increases islet yield and reduces graft immunogenicity in pancreatic islet transplantation. Transplantation 2007; 83:1397-1400.
32. Murad KL, Gosselin EJ, Eaton JW, Scott MD. Stealth cells: prevention ofmajor histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood 1999; 94:2135-2141. (Pubitemid 29430431)
33. Le Y, Scott MD. Immunocamouflage: the biophysical basis of immunoprotection by grafted methoxypoly(ethylene glycol) (mPEG). Acta Biomater 2010; 6:2631-2641.
34. Perrin H, Thaunat O, Malcus C, et al. Immunoprotection by polyethylene glycol in organ preservation solutions is not due to an immunomasking effect. Nephrol Dial Transplant 2009; 24:1682-1685.
35. Badet L, Ben Abdennebi H, Petruzzo P, et al. Effect of IGL-1, a new preservation solution, on kidney grafts (a preclinical study). Transpl Int 2005; 17:815-821. (Pubitemid 41187423)
36. Codas R, Petruzzo P, Morelon E, et al. IGL-1 solution in kidney transplantation: first multicenter study. Clin Transplant 2009; 23:337-342.
37. SchreinemachersMCJM, Doorschodt BM, Florquin S, Tolba RH. Comparison of preservation solutions for washout of kidney grafts: an experimental study. Transplant Proc 2009; 41:4072-4079.
38. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360:7-19.
39. Watson C, Wells A, Roberts RJ, et al. Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: a UK Multicenter Randomized Controlled Trial. Am J Transplant 2010; 10:1991-1999.
40. Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation 2007; 83:1289-1298. (Pubitemid 46800302)
41. Favreau F, Thuillier R, Cau J, et al. Antithrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant 2010; 10:30-39.
42. Schold JD, Kaplan B, Howard RJ, et al. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant 2005; 5:1681-1688. (Pubitemid 40910450)
43. Hosgood SA, Yang B, Bagul A, et al. A comparison of hypothermic machine perfusion versus static cold storage in an experimental model of renal ischemia reperfusion injury. Transplantation 2010; 89:830-837.
44. Flores J, DiBona DR, Beck CH, Leaf A. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest 1972; 51:118-126.
45. Summers WK, Jamison RL. The no reflow phenomenon in renal ischemia. Lab Invest 1971; 25:635-643.
46. Yamamoto T, Tada T, Brodsky SV, et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol 2002; 282:1150-1155.
47. Schmitz V, Schaser KD, Olschewski P, et al. In vivo visualization of early microcirculatory changes following ischemia/reperfusion injury in human kidney transplantation. Eur Surg Res 2008; 40:19-25. (Pubitemid 350085266)
48. McCormick SM, Eskin SG, McIntire LV, et al. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci USA 2001; 98:8955-8960. (Pubitemid 32743851)
49. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med 2009; 6:16-26.
50. Gimbrone MA Jr, Topper JN, Nagel T, et al. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 2000; 902:230-239.
51. Garcia-Cardena G, Comander J, Anderson KR, et al. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci USA 2001; 98:4478-4485. (Pubitemid 32295002)
52. Fledderus JO, van Thienen JV, Boon RA, et al. Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2. Blood 2007; 109:4249-4257. (Pubitemid 46743390)
53. SenBanerjee S, Lin Z, Atkins GB, et al. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 2004; 199:1305-1315. (Pubitemid 38685723)
54. Gracia-Sancho J, Villarreal G Jr, Zhang Y, et al. Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention. Transplantation 2010; 90:142-149.
55. Dekker RJ, Boon RA, Rondaij MG, et al. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 2006; 107:4354-4363. (Pubitemid 43801361)
56. Dekker RJ, van Thienen JV, Rohlena J, et al. Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Am J Pathol 2005; 167:609-618. (Pubitemid 43026114)
57. Adamo L, Naveiras O, Wenzel PL, et al. Biomechanical forces promote embryonic haematopoiesis. Nature 2009; 459:1131-1135.
58. Van Thienen JV, Fledderus JO, Dekker RJ, et al. Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization. Cardiovasc Res 2006; 72:231-240. (Pubitemid 44540200)
59. Parmar KM, Larman HB, Dai G, et al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 2006; 116:49-58. (Pubitemid 43121790)
60. Lin Z, Kumar A, SenBanerjee S, et al. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 2005; 96:48-57.
61. Sung RS, Christensen LL, Leichtman AB, et al. Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant 2008; 8:783-792. (Pubitemid 351347765)
62. Ciancio G, Gaynor JJ, Sageshima J, et al. Favorable outcomes with machine perfusion and longer pump times in kidney transplantation: a single-center, observational study. Transplantation 2010; 90:882-890.
63. Pegg DE, Foreman J, Hunt CJ, Diaper MP. The mechanism of action of retrograde oxygen persufflation in renal preservation. Transplantation 1989; 48:210-217. (Pubitemid 19210339)
64. Burns BD, Robson JG, Smith GK. The survival of mammalian tissues perfused with intravascular gas mixtures of oxygen and carbon dioxide. Can J Biochem Physiol 1958; 36:499-504.
65. Treckmann JW, Paul A, Saad S, et al. Primary organ function of warm ischaemically damaged porcine kidneys after retrograde oxygen persufflation. Nephrol Dial Transplant 2006; 21:1803-1808. (Pubitemid 43985706)
66. Rolles K, Foreman J, Pegg DE. A pilot clinical study of retrograde oxygen persufflation in renal preservation. Transplantation 1989; 48:339-342.
67. Dutkowski P, Graf R, Clavien PA. Rescue of the cold preserved rat liver by hypothermic oxygenated machine perfusion. Am J Transplant 2006; 6:903-912. (Pubitemid 44356640)
68. Luer B, Koetting M, Efferz P, Minor T. Role of oxygen during hypothermic machine perfusion preservation of the liver. Transpl Int 2010; 23:944-950.
69. Koetting M, Frotscher C, Minor T. Hypothermic reconditioning after cold storage improves postischemic graft function in isolated porcine kidneys. Transpl Int 2010; 23:538-542.
70. Pegg DE, Green CJ. Renal preservation by hypothermic perfusion. III. The lack of influence of pulsatile flow. Cryobiology 1976; 13:161-167.
71. Belzer FO, Ashby BS, Huang JS, Dunphy JE. Etiology of rising perfusion pressure in isolated organ perfusion. Ann Surg 1968; 168:382-391.
72. Guan Y, Karkhanis T, Wang S, et al. Physiologic benefits of pulsatile perfusion during mechanical circulatory support for the treatment of acute and chronic heart failure in adults. Artif Organs 2010; 34:529-536.
73. Travis AR, Giridharan GA, Pantalos GM, et al. Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device. J Thorac Cardiovasc Surg 2007; 133:517-524. (Pubitemid 46136291)
74. Crow S, Milano C, Joyce L, et al. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. ASAIO J 2010; 56:441-445.
75. Sandner SE, Zimpfer D, Zrunek P, et al. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant 2008; 27:469-473. (Pubitemid 351602173)
76. Ootaki C, Yamashita M, Ootaki Y, et al. Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg 2008; 136:150-158.
77. Bond M, Pitt M, Akoh J, et al. The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model. Health Technol Assess 2009; 13:1-156.
78. Buchanan PM, Lentine KL, Burroughs TE, et al. Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors. Am J Transplant 2008; 8:2391-2401.